[Apparent Correlation Between Nasopharyngeal Carcinoma and HLA Phenotype]
Overview
Authors
Affiliations
Li X, Ghandri N, Piancatelli D, Adams S, Chen D, Robbins F J Transl Med. 2007; 5:22.
PMID: 17480220 PMC: 1887520. DOI: 10.1186/1479-5876-5-22.
Provenzano M, Selleri S, Jin P, Wang E, Werden R, Slezak S Cancer Immunol Immunother. 2006; 56(7):1047-63.
PMID: 17124584 PMC: 11031044. DOI: 10.1007/s00262-006-0246-3.
Hu S, Day N, Li D, Luben R, Cai K, Ou-Yang T Br J Cancer. 2005; 92(5):967-70.
PMID: 15726104 PMC: 2361898. DOI: 10.1038/sj.bjc.6602347.
Kongruttanachok N, Sukdikul S, Setavarin S, Kerekhjanarong V, Supiyaphun P, Voravud N BMC Cancer. 2001; 1:4.
PMID: 11389775 PMC: 32196. DOI: 10.1186/1471-2407-1-4.
HLA and nasopharyngeal carcinoma in Malays.
Chan S, Chew C, Prasad U, Wee G, Srinivasan N, Kunaratnam N Br J Cancer. 1985; 51(3):389-92.
PMID: 3855643 PMC: 1976940. DOI: 10.1038/bjc.1985.52.